PT2931275T - Aclidínio para usar no aumento da atividade física na vida diária de um doente que sofre de doença pulmonar obstrutiva crónica - Google Patents
Aclidínio para usar no aumento da atividade física na vida diária de um doente que sofre de doença pulmonar obstrutiva crónicaInfo
- Publication number
- PT2931275T PT2931275T PT138053764T PT13805376T PT2931275T PT 2931275 T PT2931275 T PT 2931275T PT 138053764 T PT138053764 T PT 138053764T PT 13805376 T PT13805376 T PT 13805376T PT 2931275 T PT2931275 T PT 2931275T
- Authority
- PT
- Portugal
- Prior art keywords
- aclidinium
- daily life
- pulmonary disease
- chronic obstructive
- obstructive pulmonary
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/439—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom the ring forming part of a bridged ring system, e.g. quinuclidine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/007—Pulmonary tract; Aromatherapy
- A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
- A61K9/0075—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a dry powder inhaler [DPI], e.g. comprising micronized drug mixed with lactose carrier particles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/08—Bronchodilators
Landscapes
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Pulmonology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Otolaryngology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP12382507 | 2012-12-17 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PT2931275T true PT2931275T (pt) | 2022-06-30 |
Family
ID=47458806
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PT138053764T PT2931275T (pt) | 2012-12-17 | 2013-12-13 | Aclidínio para usar no aumento da atividade física na vida diária de um doente que sofre de doença pulmonar obstrutiva crónica |
Country Status (23)
| Country | Link |
|---|---|
| US (3) | US20150328194A1 (https=) |
| EP (1) | EP2931275B1 (https=) |
| JP (1) | JP6346618B2 (https=) |
| KR (1) | KR20150096400A (https=) |
| CN (1) | CN104869996A (https=) |
| AR (1) | AR094063A1 (https=) |
| AU (1) | AU2013363837A1 (https=) |
| CA (1) | CA2892928A1 (https=) |
| CY (1) | CY1125541T1 (https=) |
| DK (1) | DK2931275T3 (https=) |
| ES (1) | ES2917879T3 (https=) |
| HR (1) | HRP20221034T1 (https=) |
| HU (1) | HUE059569T2 (https=) |
| IL (1) | IL239245A0 (https=) |
| LT (1) | LT2931275T (https=) |
| PL (1) | PL2931275T3 (https=) |
| PT (1) | PT2931275T (https=) |
| RS (1) | RS63476B1 (https=) |
| SI (1) | SI2931275T1 (https=) |
| SM (1) | SMT202200303T1 (https=) |
| TW (1) | TW201427660A (https=) |
| UY (1) | UY35196A (https=) |
| WO (1) | WO2014095663A1 (https=) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2165768B1 (es) | 1999-07-14 | 2003-04-01 | Almirall Prodesfarma Sa | Nuevos derivados de quinuclidina y composiciones farmaceuticas que los contienen. |
| EP2100599A1 (en) | 2008-03-13 | 2009-09-16 | Laboratorios Almirall, S.A. | Inhalation composition containing aclidinium for treatment of asthma and chronic obstructive pulmonary disease |
| EP2510928A1 (en) | 2011-04-15 | 2012-10-17 | Almirall, S.A. | Aclidinium for use in improving the quality of sleep in respiratory patients |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PT837710E (pt) | 1995-06-21 | 2002-05-31 | Sofotec Gmbh & Co Kg | Cartucho de po farmaceutico com dispositivo de doseamento integrado e inalador para medicamentos em po |
| ES2165768B1 (es) | 1999-07-14 | 2003-04-01 | Almirall Prodesfarma Sa | Nuevos derivados de quinuclidina y composiciones farmaceuticas que los contienen. |
| DE10129703A1 (de) | 2001-06-22 | 2003-01-02 | Sofotec Gmbh & Co Kg | Zerstäubungssystem für eine Pulvermischung und Verfahren für Trockenpulverinhalatoren |
| ES2195785B1 (es) | 2002-05-16 | 2005-03-16 | Almirall Prodesfarma, S.A. | Nuevos derivados de piridazin-3(2h)-ona. |
| ES2211344B1 (es) | 2002-12-26 | 2005-10-01 | Almirall Prodesfarma, S.A. | Nuevos derivados de piridazin-3(2h)-ona. |
| ES2232306B1 (es) | 2003-11-10 | 2006-08-01 | Almirall Prodesfarma, S.A. | Nuevos derivados de piridazin-3(2h)-ona. |
| ES2251866B1 (es) | 2004-06-18 | 2007-06-16 | Laboratorios Almirall S.A. | Nuevos derivados de piridazin-3(2h)-ona. |
| ES2251867B1 (es) | 2004-06-21 | 2007-06-16 | Laboratorios Almirall S.A. | Nuevos derivados de piridazin-3(2h)-ona. |
| PT1616592E (pt) | 2004-07-16 | 2010-12-10 | Almirall Sa | Inalador para administração de fármacos em pó e um cartucho de pó para utilização com este inalador |
| EP2100598A1 (en) | 2008-03-13 | 2009-09-16 | Laboratorios Almirall, S.A. | Inhalation composition containing aclidinium for treatment of asthma and chronic obstructive pulmonary disease |
| EP2100599A1 (en) * | 2008-03-13 | 2009-09-16 | Laboratorios Almirall, S.A. | Inhalation composition containing aclidinium for treatment of asthma and chronic obstructive pulmonary disease |
| EP2196465A1 (en) | 2008-12-15 | 2010-06-16 | Almirall, S.A. | (3-oxo)pyridazin-4-ylurea derivatives as PDE4 inhibitors |
-
2013
- 2013-12-13 LT LTEPPCT/EP2013/076606T patent/LT2931275T/lt unknown
- 2013-12-13 CN CN201380066242.4A patent/CN104869996A/zh active Pending
- 2013-12-13 SI SI201331994T patent/SI2931275T1/sl unknown
- 2013-12-13 US US14/652,817 patent/US20150328194A1/en not_active Abandoned
- 2013-12-13 AU AU2013363837A patent/AU2013363837A1/en not_active Abandoned
- 2013-12-13 DK DK13805376.4T patent/DK2931275T3/da active
- 2013-12-13 ES ES13805376T patent/ES2917879T3/es active Active
- 2013-12-13 EP EP13805376.4A patent/EP2931275B1/en active Active
- 2013-12-13 PT PT138053764T patent/PT2931275T/pt unknown
- 2013-12-13 WO PCT/EP2013/076606 patent/WO2014095663A1/en not_active Ceased
- 2013-12-13 RS RS20220736A patent/RS63476B1/sr unknown
- 2013-12-13 PL PL13805376.4T patent/PL2931275T3/pl unknown
- 2013-12-13 HU HUE13805376A patent/HUE059569T2/hu unknown
- 2013-12-13 JP JP2015547055A patent/JP6346618B2/ja active Active
- 2013-12-13 KR KR1020157015515A patent/KR20150096400A/ko not_active Withdrawn
- 2013-12-13 HR HRP20221034TT patent/HRP20221034T1/hr unknown
- 2013-12-13 CA CA2892928A patent/CA2892928A1/en not_active Abandoned
- 2013-12-13 SM SM20220303T patent/SMT202200303T1/it unknown
- 2013-12-17 AR ARP130104797A patent/AR094063A1/es unknown
- 2013-12-17 TW TW102146516A patent/TW201427660A/zh unknown
- 2013-12-17 UY UY0001035196A patent/UY35196A/es not_active Application Discontinuation
-
2015
- 2015-06-04 IL IL239245A patent/IL239245A0/en unknown
-
2016
- 2016-07-25 US US15/218,391 patent/US20160331733A1/en not_active Abandoned
-
2017
- 2017-02-17 US US15/436,178 patent/US20180000798A1/en not_active Abandoned
-
2022
- 2022-08-29 CY CY20221100578T patent/CY1125541T1/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| DK2931275T3 (da) | 2022-07-04 |
| US20180000798A1 (en) | 2018-01-04 |
| IL239245A0 (en) | 2015-07-30 |
| JP2016502992A (ja) | 2016-02-01 |
| CY1125541T1 (el) | 2026-02-25 |
| AR094063A1 (es) | 2015-07-08 |
| CA2892928A1 (en) | 2014-06-26 |
| US20160331733A1 (en) | 2016-11-17 |
| ES2917879T3 (es) | 2022-07-12 |
| SI2931275T1 (sl) | 2022-07-29 |
| JP6346618B2 (ja) | 2018-06-20 |
| KR20150096400A (ko) | 2015-08-24 |
| UY35196A (es) | 2014-07-31 |
| LT2931275T (lt) | 2022-06-27 |
| HRP20221034T1 (hr) | 2022-11-11 |
| HUE059569T2 (hu) | 2022-11-28 |
| WO2014095663A1 (en) | 2014-06-26 |
| AU2013363837A1 (en) | 2015-06-11 |
| SMT202200303T1 (it) | 2022-09-14 |
| PL2931275T3 (pl) | 2022-09-05 |
| RS63476B1 (sr) | 2022-08-31 |
| US20150328194A1 (en) | 2015-11-19 |
| EP2931275A1 (en) | 2015-10-21 |
| CN104869996A (zh) | 2015-08-26 |
| TW201427660A (zh) | 2014-07-16 |
| EP2931275B1 (en) | 2022-06-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BR112013020115A2 (pt) | stent para imobilização de uma passagem nasal | |
| IL228925A0 (en) | Benzothiazole compounds and their pharmaceutical use | |
| IL249056B (en) | Phenothiazine diaminium salts and their use | |
| PT2683372T (pt) | Métodos e composições para o tratamento da hiperuricemia e distúrbios metabólicos associados com a hiperuricemia | |
| IL237021B (en) | Pharmaceutical composition for treatment of pulmonary arterial hypertension with mesenchymal stem cells | |
| IL229017B (en) | Oxidative retinal diseases | |
| IL233313A0 (en) | Composition of novel carbohydrate drug for treatment of human diseases | |
| IL235512B (en) | Phenylbenzamide derivatives for use in treating diseases mediated by aquaporin | |
| EP2913047A4 (en) | Pulmonary disease-specific therapeutic agent | |
| LT3646824T (lt) | Kateterinis protezinis širdies vožtuvas | |
| PT2919796T (pt) | Utilização de akkermansia para o tratamento de distúrbios metabólicos | |
| ME03025B (me) | Postupci za povećanje efikasnosti terapije kancera usmerene na folr1 | |
| PT2760475T (pt) | Proteínas de fusão para o tratamento de distúrbios metabólicos | |
| EP2670439A4 (en) | DRUG TO REDUCE UNWANTED MEDICAL CONDITIONS | |
| EP2689797A4 (en) | MEDICAL SHUTTER | |
| PT2877184T (pt) | Composições e tratamento para doenças e distúrbios oculares | |
| SG11201401343YA (en) | TREATMENT OF DISEASE OR DISORDERS CAUSED BY INDUCED NFkB TRANSCRIPTIONAL ACTIVITY | |
| IL231121A0 (en) | Treatment of degenerative joint disease | |
| BR112012015334A2 (pt) | terapia combinada para doença pulmonar obstrutiva crônica | |
| CO6950486A2 (es) | Solución para administración oral | |
| ITTO20110638A1 (it) | Composizione farmaceutica di combinazione e metodi per trattare patologie o stati patologici associati a patologie o stati patologici respiratori | |
| IL231622B (en) | Pharmaceutical composition for treatment of cachexia | |
| IL227941A0 (en) | Asymmetric ureas and medical uses thereof | |
| BR112014009789A2 (pt) | cisteamina no tratamento da doença fibrótica | |
| CO6801754A2 (es) | Una composición farmacéutica para tratar una enfermedad en la cavidad oral que comprende rebamipida |